Angiogenic activity of endothelial progenitor cells through angiopoietin-1 and angiopoietin-2

ABSTRACT Angiogenesis is a regulated process involving the proliferation, migration, and remodeling of different cell types particularly mature endothelial cells and recently discovered progenitor cells, named as endothelial progenitor cells (EPCs). Up to now, many attempts have been made to understand the dynamic balance of pro- and anti-angiogenic factors on EPCs on different milieu. It has been accepted that Ang-1, -2 and Tie-1, -2 signaling play a key role on angiogenesis pathways in endothelial lineage cells. In the current experiment, the angiogenic/angio-modulatory potency of Ang-1 and -2 was investigated on isolated EPCs. Freshly isolated EPCs were exposed to different concentrations of Ang-1 and -2 (25 and 50 ng/ml) over a course of 7 and 14 days. Corroborating to our results, a superior effect of Ang-1 on angiogenic properties, including an increased concentration of vascular endothelial growth factor, in vitro tubulogenesis, EPC migratory, Tie-2 expression and clonogenicity, was determined. A large amount of positive mature endothelium markers was achieved in EPCs being-exposed to Ang-1 peptide. Nonetheless, the number of CD133 positive cells increased in the presence of Ang-2. Collectively, we conclude that Ang-1 potentially induces functional and mature vascular-like behavior in EPCs more than Ang-2.

[1]  R. Rahbarghazi,et al.  ECM‐Dependence of Endothelial Progenitor Cell Features , 2016, Journal of cellular biochemistry.

[2]  Daniel M. Corey,et al.  Phosphorylation of Threonine 794 on Tie1 by Rac1/PAK1 Reveals a Novel Angiogenesis Regulatory Pathway , 2015, PloS one.

[3]  R. Rahbarghazi,et al.  Endothelial juxtaposition of distinct adult stem cells activates angiogenesis signaling molecules in endothelial cells , 2015, Cell and Tissue Research.

[4]  Seung Leal Paek,et al.  COMP-Ang1 Potentiates EPC Treatment of Ischemic Brain Injury by Enhancing Angiogenesis Through Activating AKT-mTOR Pathway and Promoting Vascular Migration Through Activating Tie2-FAK Pathway , 2015, Experimental neurobiology.

[5]  M. Quinn,et al.  Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden , 2014, Front. Oncol..

[6]  D. Grigoraș,et al.  Endothelial progenitor cells contribute to the development of ovarian carcinoma tumor blood vessels , 2014, Oncology letters.

[7]  Shing-Jyh Chang,et al.  Distinct angiogenesis roles and surface markers of early and late endothelial progenitor cells revealed by functional group analyses , 2013, BMC Genomics.

[8]  M. Yoder Human endothelial progenitor cells. , 2012, Cold Spring Harbor perspectives in medicine.

[9]  M. Felcht,et al.  Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling. , 2012, The Journal of clinical investigation.

[10]  Lanfang Li,et al.  Overexpression of Angiopoietin-1 Increases CD133+/c-kit+ Cells and Reduces Myocardial Apoptosis in db/db Mouse Infarcted Hearts , 2012, PloS one.

[11]  S. Egginton,et al.  Angiogenic potential of endothelial progenitor cells and embryonic stem cells , 2011, Vascular cell.

[12]  N. Mochizuki,et al.  Tie2 is tied at the cell-cell contacts and to extracellular matrix by Angiopoietin-1 , 2009, Experimental & Molecular Medicine.

[13]  J. Chute,et al.  Endothelial progenitor cell infusion induces hematopoietic stem cell reconstitution in vivo. , 2009, Blood.

[14]  E. Peterson,et al.  Common endothelial progenitor cell assays identify discrete endothelial progenitor cell populations. , 2009, American heart journal.

[15]  J. Fueyo,et al.  Tie2: a journey from normal angiogenesis to cancer and beyond. , 2008, Histology and histopathology.

[16]  Hae-June Lee,et al.  COMP-Ang1, angiopoietin-1 variant protects radiation-induced bone marrow damage in C57BL/6 mice. , 2008, Journal of radiation research.

[17]  I. Morita,et al.  A comparison of the tube forming potentials of early and late endothelial progenitor cells. , 2008, Experimental cell research.

[18]  Po-Len Liu,et al.  High Glucose Impairs Early and Late Endothelial Progenitor Cells by Modifying Nitric Oxide–Related but Not Oxidative Stress–Mediated Mechanisms , 2007, Diabetes.

[19]  T. Asahara,et al.  CD34-Positive Cells Exhibit Increased Potency and Safety for Therapeutic Neovascularization After Myocardial Infarction Compared With Total Mononuclear Cells , 2006, Circulation.

[20]  M. Vidaud,et al.  The angiopoietin pathway is modulated by PAR‐1 activation on human endothelial progenitor cells , 2006, Journal of thrombosis and haemostasis : JTH.

[21]  D. Dumont,et al.  Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization , 2006, Journal of Cell Science.

[22]  M. Mizuno,et al.  Combination of In Vivo Angiopoietin-1 Gene Transfer and Autologous Bone Marrow Cell Implantation for Functional Therapeutic Angiogenesis , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[23]  K. Alitalo,et al.  Signaling and Functions of Angiopoietin-1 in Vascular Protection , 2006, Circulation research.

[24]  G. Nickenig,et al.  CD34−/CD133+/VEGFR-2+ Endothelial Progenitor Cell Subpopulation With Potent Vasoregenerative Capacities , 2006, Circulation research.

[25]  H. Augustin,et al.  The Tie-2 ligand Angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism , 2005, Journal of Cell Science.

[26]  B. Torbett,et al.  The role of angiopoietins in the development of endothelial cells from cord blood CD34+ progenitors. , 2004, Blood.

[27]  T. Asahara,et al.  Endothelial progenitor cells for postnatal vasculogenesis. , 2004, American journal of physiology. Cell physiology.

[28]  S. Dimmeler,et al.  Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.

[29]  Keisuke Ito,et al.  Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow Niche , 2004, Cell.

[30]  Jinyun Zhu,et al.  Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood. , 2004, Journal of molecular and cellular cardiology.

[31]  Hyun-Jae Kang,et al.  Characterization of Two Types of Endothelial Progenitor Cells and Their Different Contributions to Neovasculogenesis , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[32]  Rakesh K Jain,et al.  Molecular regulation of vessel maturation , 2003, Nature Medicine.

[33]  Richard A. Lang,et al.  Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Skobe,et al.  Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth. , 2002, The American journal of pathology.

[35]  J. Mulliken,et al.  Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells. , 2001, The American journal of pathology.

[36]  S. Fichtlscherer,et al.  Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease , 2001, Circulation research.

[37]  D. Dumont,et al.  The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R , 1998, Oncogene.

[38]  J. Isner,et al.  Chemotactic Properties of Angiopoietin-1 and -2, Ligands for the Endothelial-specific Receptor Tyrosine Kinase Tie2* , 1998, The Journal of Biological Chemistry.

[39]  S. Nishikawa,et al.  PDGFRα Expression During Mouse Embryogenesis: Immunolocalization Analyzed by Whole-mount Immunohistostaining Using the Monoclonal Anti-mouse PDGFRα Antibody APA5 , 1997 .

[40]  Pamela F. Jones,et al.  Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.

[41]  A. Iwama,et al.  Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells. , 1993, Biochemical and biophysical research communications.